The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.8M data for 1.2M Compounds and 9.2K Targets. Of those, 1,346K data for 622K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

34 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Influence of azide incorporation on binding affinity by small papain inhibitors.EBI
Radboud University Nijmegen
Squaric acid/4-aminoquinoline conjugates: novel potent antiplasmodial agents.EBI
University Of Lisbon. Av. Prof. Gama Pinto
Design, synthesis, and optimization of novel epoxide incorporating peptidomimetics as selective calpain inhibitors.EBI
University Of Illinois College Of Pharmacy
Inhibition of rhodesain as a novel therapeutic modality for human African trypanosomiasis.EBI
Universit£
Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.EBI
Smithkline Beecham Pharmaceuticals
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.EBI
Korea Research Institute Of Bioscience And Biotechnology
Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.EBI
University Of Florida
Natural polyprenylated benzophenones inhibiting cysteine and serine proteases.EBI
Federal University Of Alfenas
Protease inhibitors: current status and future prospects.EBI
University Of Queensland
Peptidyl beta-homo-aspartals: specific inhibitors of interleukin-1 beta converting enzyme and its homologues (caspases).EBI
Institute For Drug Research
Design, synthesis and biological evaluation of peptidyl-vinylaminophosphonates as novel cysteine protease inhibitors.EBI
National Chemical Laboratory (Csir-Ncl)
Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents.EBI
University Of Lisbon
HLE-inhibitory alkaloids with a polyketide skeleton from the marine-derived fungus Coniothyrium cereale.EBI
University Of Bonn
Antimalarial activity of azadipeptide nitriles.EBI
University Of Queensland
Identification and optimization of inhibitors of Trypanosomal cysteine proteases: cruzain, rhodesain, and TbCatB.EBI
National Human Genome Research Institute
 
Design of a new selective cysteine protease inactivator and its mechanistic implicationsEBI
TBA
Peptidyl epoxides extended in the P' direction as cysteine protease inhibitors: effect on affinity and mechanism of inhibition.EBI
Bar-Ilan University
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.EBI
Peking University
Azapeptides structurally based upon inhibitory sites of cystatins as potent and selective inhibitors of cysteine proteases.EBI
University Of Gda£?Sk
Discovery, total synthesis, HRV 3C-protease inhibitory activity, and structure-activity relationships of 2-methoxystypandrone and its analogues.EBI
Merck Research Laboratories
Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.EBI
Merck Frosst Centre For Therapeutic Research
(S)-Thiirancarboxylic acid as a reactive building block for a new class of cysteine protease inhibitors.EBI
University Of WüRzburg
Combinatorial library of serine and cysteine protease inhibitors that interact with both the S and S' binding sites.EBI
Brown University
Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.EBI
University Of Wisconsin
Peptide alpha-keto ester, alpha-keto amide, and alpha-keto acid inhibitors of calpains and other cysteine proteases.EBI
Georgia Institute Of Technology
Nonpeptidic inhibitors of human leukocyte elastase. 2. Design, synthesis, and in vitro activity of a series of 3-amino-6-arylopyridin-2-one trifluoromethyl ketones.EBI
Zeneca Pharmaceuticals Group
Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 3. In vitro and in vivo potency of a series of peptidyl alpha-ketobenzoxazoles.EBI
Zeneca Pharmaceuticals
Vinylogous amino acid esters: a new class of inactivators for thiol proteases.EBI
TBA
Carboxyl-modified amino acids and peptides as protease inhibitors.EBI
TBA
Acid-sensitive latent inhibitors for proteolytic enzymes: synthesis and characterization.EBI
Amherst College
A neoceptor approach to unraveling microscopic interactions between the human A2A adenosine receptor and its agonists.BDB
National Institutes Of Health